Approval · Notice of Compliance 17560 · 2015
NARDIL: Notice of Compliance 17560
Issued December 14, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17560
- Date
- December 14, 2015
- Company
- Erfa Canada 2012 Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the warnings and precautions and consumer information of the product monograph reflecting (verbatim) the class labelling for antidepressants describing teh potential side effect and risk factors for angle closure glaucoma
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NARDIL | Not yet assigned | — |
Medicinal ingredients
- PHENELZINE SULFATE 15 MG per TAB